TechNVision Ventures Ltd has announced a significant collaboration through a BSE filing dated March 18, 2026, regarding a Memorandum of Understanding between its affiliate Solix Technologies and Symbiosis Center for Entrepreneurship & Innovation. The MoU establishes a Center of Excellence in New Drug Development and Drug Repurposing, marking a strategic advancement in AI-driven healthcare innovation.

Strategic Partnership Details

The collaboration brings together Solix Technologies and Symbiosis Center for Entrepreneurship & Innovation in partnership with Symbiosis Medical College for Women to create a comprehensive research ecosystem. The MoU was formalized during TAL HealthFest 2026, demonstrating the commitment of both institutions to advance innovation at the intersection of Artificial Intelligence, biomedical research, and translational medicine.

Center of Excellence Framework

The Center of Excellence aims to integrate multiple research methodologies to accelerate drug discovery processes. The initiative combines computational intelligence with clinical validation to address current challenges in pharmaceutical development.

Core Integration Areas:

• Computational intelligence and AI-driven in-silico modeling
• Molecular validation frameworks
• In-vivo translational research

Initial Research Focus:

• Alzheimer's disease therapeutics
• Priority Antimicrobial Resistant (PAMR) pathogens

The collaboration leverages Solix's 25+ years of expertise in end-to-end data lifecycle management, governance, and Enterprise AI, combined with SMCW's clinical, translational, and biomedical research strengths.

Addressing Industry Challenges

The drug discovery and development landscape faces significant obstacles including high pre-clinical attrition rates, extended development timelines, and escalating R&D costs. This initiative aligns with national missions supported by India's DBT, ICMR, DST, and AMR action plans, contributing toward scientific self-reliance and healthcare innovation.

Leadership Vision and Impact

According to Mr. Sai Gundavelli, Founder & CEO of Solix Technologies, the partnership focuses on intelligent data harmonization and AI-driven translational science to accelerate therapeutic breakthroughs while reducing pre-clinical risk. Dr. Saptarishi Ghosh, CEO of SCEI at Symbiosis International University, emphasized that the collaboration strengthens their mission to empower women in medicine and advance translational healthcare research.

Technology and Research Integration

Mr. Murali Krishnam, VP - Pharma AI Product Strategy at Solix Technologies, highlighted the company's leadership in advanced Semantic Layering and Neuro-Symbolic AI. The platform addresses the complexity of integrating in-silico, in-vitro, and in-vivo research data ecosystems, enabling organizations to unlock unified insights and transform research into real-world impact.

The Center of Excellence will identify and validate novel therapeutic targets, develop CNS-active and antimicrobial lead molecules, and repurpose approved and investigational drugs. Additionally, it will enable industry collaboration and CRO services, support intellectual property generation, and train undergraduate, postgraduate, and PhD scholars in translational drug development.

Technvision Ventures Ltd. has announced that its affiliate Solix Technologies has expanded its global leadership team with four strategic executive appointments, reinforcing the company's commitment to helping enterprises modernize their data infrastructure and accelerate AI-driven innovation.

Strategic Leadership Appointments

Solix Technologies has made four key appointments to strengthen its global operations and customer engagement capabilities. The new leadership team includes Bryan Powell as Senior Vice President of Professional Services, David Zuccolotto's promotion to Global Vice President of Sales, Matthew Long as Vice President of Sales for Europe, and Bob Wright as Vice President of Sales for Canada.

According to Sai Gundavelli, Founder and CEO of Solix Technologies, these appointments significantly strengthen the company's ability to help organizations modernize their data infrastructure, reduce legacy data risk, and accelerate AI-driven innovation.

Professional Services Leadership Enhancement

Bryan Powell joins Solix Technologies as Senior Vice President of Professional Services, bringing more than 20 years of global enterprise services leadership experience across SaaS, AI, cybersecurity, and data platforms. Powell will lead global delivery strategy, implementation excellence, and customer lifecycle value creation to ensure accelerated time-to-value for Solix customers.

Powell has held senior leadership roles at major technology companies including IBM, Cloudera, and Teradata, where he built and scaled global professional services organizations supporting Fortune 1000 enterprises. He holds a Master of Arts in Leadership and Administration from the University of Colorado and a Bachelor of Science degree from Colorado State University.

Global Sales Strategy Expansion

David Zuccolotto has been promoted to Global Vice President of Sales, recognizing his leadership and strategic impact in driving enterprise growth initiatives. With nearly 30 years of experience as a seasoned entrepreneur and enterprise technology executive, Zuccolotto will lead Solix's international sales strategy and strengthen key enterprise partnerships.

In his expanded global role, Zuccolotto will focus on driving adoption of the company's Enterprise AI and Information Architecture platforms, working closely with CIOs, CDOs, and enterprise architecture leaders to help organizations streamline data workflows and accelerate AI-powered transformation.

Regional Market Development

Matthew Long joins as Vice President of Sales for Europe, bringing more than 15 years of enterprise technology leadership and sales experience. Prior to joining Solix, Long served as Head of Modern Workspace at CDW, where he led digital workplace and cloud transformation initiatives for enterprise customers across the United Kingdom during his nearly 17-year career at the company.

Bob Wright has been appointed Vice President of Sales for Canada, contributing more than 25 years of enterprise technology leadership experience. Wright has worked with industry-leading technology companies including OpenText, Citrix, McAfee, Symantec, and Softchoice. Prior to joining Solix, he served as Senior Director at Messaging Architects, leading strategic initiatives focused on infrastructure modernization and regulatory compliance.

Company Background and Strategic Focus

Solix Technologies specializes in enterprise data management, information lifecycle governance, and AI-ready data platforms. The company's Common Data Platform and Enterprise AI solutions provide intelligent data classification, comprehensive governance, and semantic layers that create foundations for production-ready AI systems.

Technvision Ventures Limited positions itself as a pioneer in creating next-generation enterprise software businesses, innovating and incubating new ideas in emerging technology areas. The company serves as the parent organization for Solix Technologies Inc., supporting its mission to help enterprises become AI-native while maintaining compliance with emerging AI regulations across various industries including healthcare, pharmaceutical, financial services, retail, and manufacturing sectors.